European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection

Clinical Microbiology and Infection

Volumn 22, Issue , 2016, Pages S63-S81

  Crobach, M J T ^a   Planche, T ^c   Eckert, C ^d   Barbut, F ^d   Terveer, E M ^a   Dekkers, O M ^a,b   Wilcox, M H ^e   Kuijper, E J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AARHUS UNIVERSITY   (Denmark)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d National Reference Laboratory for Clostridium difficile   (France)

^e LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Clostridium difficile infection; diagnosis; guideline; recommendations; review

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; GLUTAMATE DEHYDROGENASE; BACTERIAL DNA; BACTERIAL TOXIN; DIAGNOSTIC KIT;

AGE; ARTICLE; BACTERIUM CULTURE; CLOSTRIDIUM DIFFICILE INFECTION; CONSENSUS; CYTOTOXICITY ASSAY; ENZYME ASSAY; ENZYME IMMUNOASSAY; EVIDENCE BASED PRACTICE; FECES ANALYSIS; HUMAN; ILEUS; LABORATORY DIAGNOSIS; META ANALYSIS; MOLECULAR TYPING; NUCLEIC ACID AMPLIFICATION; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; REPEAT PROCEDURE; SMEAR; SYSTEMATIC REVIEW; TOXIN ANALYSIS; ALGORITHM; CLOSTRIDIUM INFECTIONS; DIAGNOSTIC KIT; EARLY DIAGNOSIS; EUROPEAN UNION; GENETICS; HEALTH SURVEY; ISOLATION AND PURIFICATION; MEDICAL SOCIETY; METABOLISM; MICROBIOLOGY; ORGANIZATION AND MANAGEMENT; PEPTOCLOSTRIDIUM DIFFICILE; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DNA, BACTERIAL; EARLY DIAGNOSIS; EUROPEAN UNION; HUMANS; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL;

EID: 84979016970     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.03.010     Document Type: Article

References (91)

1. [1] Crobach, M.J., Dekkers, O.M., Wilcox, M.H., Kuijper, E.J., European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile–infection (CDI). Clin Microbiol Infect 15 (2009), 1053–1066.
2. [2] Planche, T., Wilcox, M., Reference assays for Clostridium difficile infection: one or two gold standards?. J Clin Pathol 64 (2011), 1–5.
3. [3] Delmee, M., Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect 7 (2001), 411–416.
4. [4] Hink, T., Burnham, C.A., Dubberke, E.R., A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens. Anaerobe 19 (2013), 39–43.
5. [5] Borriello, S.P., Honour, P., Simplified procedure for the routine isolation of Clostridium difficile from faeces. J Clin Pathol 34 (1981), 1124–1127.
6. [6] Burnham, C.A., Carroll, K.C., Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 26 (2013), 604–630.
7. [7] Lalande, V., Barrault, L., Wadel, S., Eckert, C., Petit, J.C., Barbut, F., Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections. J Clin Microbiol 49 (2011), 2714–2716.
8. [8] Eckert, C., Holscher, E., Petit, A., Lalande, V., Barbut, F., Molecular test based on isothermal helicase-dependent amplification for detection of the Clostridium difficile toxin A gene. J Clin Microbiol 52 (2014), 2386–2389.
9. [9] Nyc, O., Pituch, H., Matejkova, J., Obuch-Woszczatynski, P., Kuijper, E.J., Clostridium difficile PCR ribotype 176 in the Czech Republic and Poland. Lancet, 377(9775), 2011, 1407.
10. [10] Whiting, P.F., Rutjes, A.W., Westwood, M.E., Mallett, S., Deeks, J.J., Reitsma, J.B., et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155 (2011), 529–536.
11. [11] Cohen, S.H., Gerding, D.N., Johnson, S., Kelly, C.P., Loo, V.G., McDonald, L.C., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31 (2010), 431–455.
12. [12] Cheng, A.C., Ferguson, J.K., Richards, M.J., Robson, J.M., Gilbert, G.L., McGregor, A., et al. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection. Med J Aust 194 (2011), 353–358.
13. [13] Surawicz, C.M., Brandt, L.J., Binion, D.G., Ananthakrishnan, A.N., Curry, S.R., Gilligan, P.H., et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108 (2013), 478–498.
14. [14] Schutze, G.E., Willoughby, R.E., Clostridium difficile infection in infants and children. Pediatrics 131 (2013), 196–200.
15. [15] Department of Health, Updated guidance on the diagnosis and reporting of Clostridium difficile., 2012, NHS, London.
16. [16] Brouwers, M.C., Kho, M.E., Browman, G.P., Burgers, J.S., Cluzeau, F., Feder, G., et al. AGREE II: advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol 63 (2010), 1308–1311.
17. [17] Schunemann, H.J., Oxman, A.D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G.E., et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336:7653 (2008), 1106–1110.
18. [18] Guyatt, G.H., Schunemann, H.J., Djulbegovic, B., Akl, E.A., Guideline panels should not GRADE good practice statements. J Clin Epidemiol 68 (2015), 597–600.
19. [19] Barkin, J.A., Nandi, N., Miller, N., Grace, A., Barkin, J.S., Sussman, D.A., Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests. Dig Dis Sci 57 (2012), 2592–2599.
20. [20] Berry, N., Sewell, B., Jafri, S., Puli, C., Vagia, S., Lewis, A.M., et al. Real-time polymerase chain reaction correlates well with clinical diagnosis of Clostridium difficile infection. J Hosp Infect 87 (2014), 109–114.
21. [21] Bruins, M.J., Verbeek, E., Wallinga, J.A., Bruijnesteijn van Coppenraet, L.E., Kuijper, E.J., Bloembergen, P., Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis 31 (2012), 3035–3039.
22. [22] Buchan, B.W., Mackey, T.L., Daly, J.A., Alger, G., Denys, G.A., Peterson, L.R., et al. Multicenter clinical evaluation of the Portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens. J Clin Microbiol 50 (2012), 3932–3936.
23. [23] Calderaro, A., Buttrini, M., Martinelli, M., Gorrini, C., Montecchini, S., Medici, M.C., et al. Comparative analysis of different methods to detect Clostridium difficile infection. New Microbiol 36 (2013), 57–63.
24. [24] Carroll, K.C., Buchan, B.W., Tan, S., Stamper, P.D., Riebe, K.M., Pancholi, P., et al. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay. J Clin Microbiol 51 (2013), 4120–4125.
25. [25] de Boer, R.F., Wijma, J.J., Schuurman, T., Moedt, J., Dijk-Alberts, B.G., Ott, A., et al. Evaluation of a rapid molecular screening approach for the detection of toxigenic Clostridium difficile in general and subsequent identification of the tcdC Delta117 mutation in human stools. J Microbiol Methods 83 (2010), 59–65.
26. [26] de Jong, E., de Jong, A.S., Bartels, C.J., van der Rijt-van den Biggelaar, C., Melchers, W.J., Sturm, P.D., Clinical and laboratory evaluation of a real-time PCR for Clostridium difficile toxin A and B genes. Eur J Clin Microbiol Infect Dis 31 (2012), 2219–2225.
27. [27] Eastwood, K., Else, P., Charlett, A., Wilcox, M., Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 47 (2009), 3211–3217.
28. [28] Fenner, L., Widmer, A.F., Goy, G., Rudin, S., Frei, R., Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 46 (2008), 328–330.
29. [29] Hart, J., Putsathit, P., Knight, D.R., Sammels, L., Riley, T.V., Keil, A., Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies. Eur J Clin Microbiol Infect Dis 33 (2014), 1555–1564.
30. [30] Hirvonen, J.J., Mentula, S., Kaukoranta, S.S., Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of toxigenic Clostridium difficile in fecal specimens. J Clin Microbiol 51 (2013), 2908–2912.
31. [31] Huang, H., Weintraub, A., Fang, H., Nord, C.E., Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of Clostridium difficile infections. J Clin Microbiol 47 (2009), 3729–3731.
32. [32] Jacobs, J., Rudensky, B., Dresner, J., Berman, A., Sonnenblick, M., van, D.Y., et al. Comparison of four laboratory tests for diagnosis of Clostridium difficile–associated diarrhea. Eur J Clin Microbiol Infect Dis 15 (1996), 561–566.
33. [33] Kawada, M., Annaka, M., Kato, H., Shibasaki, S., Hikosaka, K., Mizuno, H., et al. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection. J Infect Chemother 17 (2011), 807–811.
34. [34] Kim, H., Jeong, S.H., Kim, M., Lee, Y., Lee, K., Detection of Clostridium difficile toxin A/B genes by multiplex real-time PCR for the diagnosis of C. difficile infection. J Med Microbiol 61:Pt 2 (2012), 274–277.
35. [35] Kim, H., Kim, W.H., Kim, M., Jeong, S.H., Lee, K., Evaluation of a rapid membrane enzyme immunoassay for the simultaneous detection of glutamate dehydrogenase and toxin for the diagnosis of Clostridium difficile infection. Ann Lab Med 34 (2014), 235–239.
36. [36] Larson, A.M., Fung, A.M., Fang, F.C., Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J Clin Microbiol 48 (2010), 124–130.
37. [37] Le Guern, Herwegh, S., Grandbastien, B., Courcol, R., Wallet, F., Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples. J Clin Microbiol 50 (2012), 3089–3090.
38. [38] Leitner, E., Einetter, M., Grisold, A.J., Marth, E., Feierl, G., Evaluation of the BD MAX Cdiff assay for the detection of the toxin B gene of Clostridium difficile out of faecal specimens. Diagn Microbiol Infect Dis 76 (2013), 390–391.
39. [39] Massey, V., Gregson, D.B., Chagla, A.H., Storey, M., John, M.A., Hussain, Z., Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea. Am J Clin Pathol 119 (2003), 45–49.
40. [40] Mattner, F., Winterfeld, I., Mattner, L., Diagnosing toxigenic Clostridium difficile: new confidence bounds show culturing increases sensitivity of the toxin A/B enzyme immunoassay and refute gold standards. Scand J Infect Dis 44 (2012), 578–585.
41. [41] Musher, D.M., Manhas, A., Jain, P., Nuila, F., Waqar, A., Logan, N., et al. Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay. J Clin Microbiol 45 (2007), 2737–2739.
42. [42] Noren, T., Alriksson, I., Andersson, J., Akerlund, T., Unemo, M., Rapid and sensitive loop-mediated isothermal amplification test for Clostridium difficile detection challenges cytotoxin B cell test and culture as gold standard. J Clin Microbiol 49 (2011), 710–711.
43. [43] Novak-Weekley, S.M., Marlowe, E.M., Miller, J.M., Cumpio, J., Nomura, J.H., Vance, P.H., et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol 48 (2010), 889–893.
44. [44] O'Connor, D., Hynes, P., Cormican, M., Collins, E., Corbett-Feeney, G., Cassidy, M., Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile–associated diarrhea. J Clin Microbiol 39 (2001), 2846–2849.
45. [45] Ota, K.V., McGowan, K.L., Clostridium difficile testing algorithms using glutamate dehydrogenase antigen and C. difficile toxin enzyme immunoassays with C. difficile nucleic acid amplification testing increase diagnostic yield in a tertiary pediatric population. J Clin Microbiol 50 (2012), 1185–1188.
46. [46] Pancholi, P., Kelly, C., Raczkowski, M., Balada-Llasat, J.M., Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays. J Clin Microbiol 50 (2012), 1331–1335.
47. [47] Planche, T.D., Davies, K.A., Coen, P.G., Finney, J.M., Monahan, I.M., Morris, K.A., et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection. Lancet Infect Dis 13 (2013), 936–945.
48. [48] Qutub, M.O., AlBaz, N., Hawken, P., Anoos, A., Comparison between the two-step and the three-step algorithms for the detection of toxigenic Clostridium difficile. Indian J Med Microbiol 29 (2011), 293–296.
49. [49] Reller, M.E., Lema, C.A., Perl, T.M., Cai, M., Ross, T.L., Speck, K.A., et al. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol 45 (2007), 3601–3605.
50. [50] Reller, M.E., Alcabasa, R.C., Lema, C.A., Carroll, K.C., Comparison of two rapid assays for Clostridium difficile Common antigen and a C difficile toxin A/B assay with the cell culture neutralization assay. Am J Clin Pathol 133 (2010), 107–109.
51. + C. difficile prevalent area. Anaerobe 15 (2009), 266–269.
52. [52] Shin, B.M., Kuak, E.Y., Lee, E.J., Songer, J.G., Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection. J Clin Microbiol 47 (2009), 2952–2956.
53. [53] Shin, B.M., Mun, S.J., Yoo, S.J., Kuak, E.Y., Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens. J Clin Microbiol 50 (2012), 3765–3767.
54. [54] Shin, S., Kim, M., Kim, M., Lim, H., Kim, H., Lee, K., et al. Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection. Ann Lab Med 32 (2012), 355–358.
55. [55] Sloan, L.M., Duresko, B.J., Gustafson, D.R., Rosenblatt, J.E., Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol 46 (2008), 1996–2001.
56. [56] Snell, H., Ramos, M., Longo, S., John, M., Hussain, Z., Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile–associated diarrhea. J Clin Microbiol 42 (2004), 4863–4865.
57. [57] Soh, Y.S., Yang, J.J., You, E., La, J.Y., Kim, M.J., Nam, Y.S., et al. Comparison of two molecular methods for detecting toxigenic Clostridium difficile. Ann Clin Lab Sci 44 (2014), 27–31.
58. [58] Stamper, P.D., Babiker, W., Alcabasa, R., Aird, D., Wehrlin, J., Ikpeama, I., et al. Evaluation of a new commercial TaqMan PCR assay for direct detection of the Clostridium difficile toxin B gene in clinical stool specimens. J Clin Microbiol 47 (2009), 3846–3850.
59. [59] Stamper, P.D., Alcabasa, R., Aird, D., Babiker, W., Wehrlin, J., Ikpeama, I., et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol 47 (2009), 373–378.
60. [60] Staneck, J.L., Weckbach, L.S., Allen, S.D., Siders, J.A., Gilligan, P.H., Coppitt, G., et al. Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination. J Clin Microbiol 34 (1996), 2718–2721.
61. [61] Swindells, J., Brenwald, N., Reading, N., Oppenheim, B., Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol 48 (2010), 606–608.
62. [62] Tenover, F.C., Novak-Weekley, S., Woods, C.W., Peterson, L.R., Davis, T., Schreckenberger, P., et al. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol 48 (2010), 3719–3724.
63. [63] Terhes, G., Urban, E., Soki, J., Nacsa, E., Nagy, E., Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces. J Clin Microbiol 47 (2009), 3478–3481.
64. [64] Ticehurst, J.R., Aird, D.Z., Dam, L.M., Borek, A.P., Hargrove, J.T., Carroll, K.C., Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 44 (2006), 1145–1149.
65. [65] Turgeon, D.K., Novicki, T.J., Quick, J., Carlson, L., Miller, P., Ulness, B., et al. Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay. J Clin Microbiol 41 (2003), 667–670.
66. [66] Van den Berg, R.J., Bruijnesteijn van Coppenraet, L.S., Gerritsen, H.J., Endtz, H.P., van d, V., Kuijper, E.J., Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile–associated diarrhea in hospitalized patients. J Clin Microbiol 43 (2005), 5338–5340.
67. [67] Van den Berg, R.J., Vaessen, N., Endtz, H.P., Schulin, T., van d, V., Kuijper, E.J., Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile–associated diarrhoea in a prospective multicentre study. J Med Microbiol 56:Pt 1 (2007), 36–42.
68. [68] Vanpoucke, H., De, B.T., Claeys, G., Vaneechoutte, M., Verschraegen, G., Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens. Clin Microbiol Infect 7 (2001), 55–64.
69. [69] Viala, C., Le, M.A., Maataoui, N., Rousseau, C., Collignon, A., Poilane, I., Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and Illumigene C. difficile. J Microbiol Methods 90 (2012), 83–85.
70. [70] Walkty, A., Lagace-Wiens, P.R., Manickam, K., Adam, H., Pieroni, P., Hoban, D., et al. Evaluation of an algorithmic approach in comparison with the Illumigene assay for laboratory diagnosis of Clostridium difficile infection. J Clin Microbiol 51 (2013), 1152–1157.
71. [71] Wren, M.W., Kinson, R., Sivapalan, M., Shemko, M., Shetty, N.R., Detection of Clostridium difficile infection: a suggested laboratory diagnostic algorithm. Br J Biomed Sci 66 (2009), 175–179.
72. [72] Zheng, L., Keller, S.F., Lyerly, D.M., Carman, R.J., Genheimer, C.W., Gleaves, C.A., et al. Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J Clin Microbiol 42 (2004), 3837–3840.
73. [73] Davies, K.A., Longshaw, C.M., Davis, G.L., Bouza, E., Barbut, F., Barna, Z., et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis 14 (2014), 1208–1219.
74. [74] Barbut, F., Surgers, L., Eckert, C., Visseaux, B., Cuingnet, M., Mesquita, C., et al. Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management?. Clin Microbiol Infect 20 (2014), 136–144.
75. [75] Goorhuis, A., Debast, S.B., Dutilh, J.C., van Kinschot, C.M., Harmanus, C., Cannegieter, S.C., et al. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin Infect Dis 53 (2011), 860–869.
76. [76] Curry, S.R., Muto, C.A., Schlackman, J.L., Pasculle, A.W., Shutt, K.A., Marsh, J.W., et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 57 (2013), 1094–1102.
77. [77] Eyre, D.W., Griffiths, D., Vaughan, A., Golubchik, T., Acharya, M., O'Connor, L., et al. Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One, 8, 2013, e78445.
78. [78] Aichinger, E., Schleck, C.D., Harmsen, W.S., Nyre, L.M., Patel, R., Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol 46 (2008), 3795–3797.
79. [79] Debast, S.B., van, K.E., Oskam, K.M., van den Berg, T., Van den Berg, R.J., Kuijper, E.J., Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile–associated disease. Clin Microbiol Infect 14 (2008), 622–624.
80. [80] Sethi, A.K., Al-Nassir, W.N., Nerandzic, M.M., Bobulsky, G.S., Donskey, C.J., Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol 31 (2010), 21–27.
81. [81] Wenisch, C., Parschalk, B., Hasenhundl, M., Hirschl, A.M., Graninger, W., Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile–associated diarrhea. Clin Infect Dis 22 (1996), 813–818.
82. [82] Hensgens, M.P., Dekkers, O.M., Demeulemeester, A., Buiting, A.G., Bloembergen, P., van Benthem, B.H., et al. Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case–control study. Clin Microbiol Infect 20 (2014), O1067–O1074.
83. [83] Bauer, M.P., Veenendaal, D., Verhoef, L., Bloembergen, P., van Dissel, J.T., Kuijper, E.J., Clinical and microbiological characteristics of community-onset Clostridium difficile infection in the Netherlands. Clin Microbiol Infect 15 (2009), 1087–1092.
84. [84] Wilcox, M.H., Mooney, L., Bendall, R., Settle, C.D., Fawley, W.N., A case–control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 62 (2008), 388–396.
85. [85] Alcala, L., Martin, A., Marin, M., Sanchez-Somolinos, M., Catalan, P., Pelaez, T., et al. The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem?. Clin Microbiol Infect 18 (2012), E204–E213.
86. [86] Reigadas, E., Alcala, L., Marin, M., Burillo, A., Munoz, P., Bouza, E., Missed diagnosis of Clostridium difficile infection; a prospective evaluation of unselected stool samples. J Infect 70 (2015), 264–272.
87. [87] Bryant, K., McDonald, L.C., Clostridium difficile infections in children. Pediatr Infect Dis J 28 (2009), 145–146.
88. [88] Wendt, J.M., Cohen, J.A., Mu, Y., Dumyati, G.K., Dunn, J.R., Holzbauer, S.M., et al. Clostridium difficile infection among children across diverse US geographic locations. Pediatrics 133 (2014), 651–658.
89. [89] Rogers, D.S., Kundrapu, S., Sunkesula, V.C., Donskey, C.J., Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficile. J Clin Microbiol 51 (2013), 3421–3422.
90. [90] McFarland, L.V., Coyle, M.B., Kremer, W.H., Stamm, W.E., Rectal swab cultures for Clostridium difficile surveillance studies. J Clin Microbiol 25 (1987), 2241–2242.
91. [91] Kundrapu, S., Sunkesula, V.C., Jury, L.A., Sethi, A.K., Donskey, C.J., Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection. Clin Infect Dis 55 (2012), 1527–1530.